Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology

Nutrition Journal

Volumn 9, Issue 1, 2010, Pages

  Vashi, Pankaj G ^a   Trukova, Kristen ^a   Lammersfeld, Carolyn A ^a   Braun, Donald P ^a   Gupta, Digant ^a  

^a CANCER TREATMENT CENTERS OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; 25-HYDROXYVITAMIN D; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; VITAMIN D;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER THERAPY; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ONCOLOGY; PANCREAS CANCER; PROSTATE CANCER; RETROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; COLORECTAL TUMOR; DIET THERAPY; LUNG TUMOR; MIDDLE AGED; NEOPLASM; PANCREAS TUMOR; PROSTATE TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHOLECALCIFEROL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78549289570     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-9-60     Document Type: Article

References (47)

1. Estimates of optimal vitamin D status. B Dawson-Hughes RP Heaney MF Holick P Lips PJ Meunier R Vieth, Osteoporos Int 2005 16 713 716 10.1007/s00198-005-1867-7 15776217
2. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. BW Hollis, J Nutr 2005 135 317 322 15671234
3. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. HA Bischoff-Ferrari, Adv Exp Med Biol 2008 624 55 71 55-71 full-text 18348447
4. Serum Vitamin D Concentration and Prostate Cancer Risk: A Nested Case-Control Study. J Ahn U Peters D Albanes MP Purdue CC Abnet N Chatterjee RL Horst BW Hollis WY Huang JM Shikany RB Hayes, J Natl Cancer Inst 2008 100 11 796 804 10.1093/jnci/djn152 18505967
5. Vitamin D and Prostate Cancer Risk - A Less Sunny Outlook? LA Mucci D Spiegelman, J Natl Cancer Inst 2008 100 11 759 61 10.1093/jnci/djn164 18505963
6. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer - results of a large case-control study. S Abbas J Linseisen T Slanger S Kropp EJ Mutschelknauss D Flesch-Janys J Chang-Claude, Carcinogenesis 2008 29 93 99 10.1093/carcin/bgm240 17974532
7. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. RS Heist W Zhou Z Wang G Liu D Neuberg L Su K Asomaning BW Hollis TJ Lynch JC Wain E Giovannucci DC Christiani, J Clin Oncol 2008 26 5596 5602 10.1200/JCO.2008.18.0406 18936471
8. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. K Ng JA Meyerhardt K Wu D Feskanich BW Hollis EL Giovannucci CS Fuchs, J Clin Oncol 2008 26 2984 2991 10.1200/JCO.2007.15.1027 18565885
9. Association between serum 25(OH)D and death from prostate cancer. S Tretli E Hernes JP Berg UE Hestvik TE Robsahm, Br J Cancer 2009 100 450 454 10.1038/sj.bjc.6604865 19156140
10. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. W Zhou RS Heist G Liu K Asomaning DS Neuberg BW Hollis JC Wain TJ Lynch E Giovannucci L Su DC Christiani, J Clin Oncol 2007 25 479 485 10.1200/JCO.2006.07.5358 17290055
11. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. RZ Stolzenberg-Solomon R Vieth A Azad P Pietinen PR Taylor J Virtamo D Albanes, Cancer Res 2006 66 10213 10219 10.1158/0008-5472.CAN-06-1876 17047087
12. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. WB Grant, Cancer 2002 94 1867 1875 10.1002/cncr.10427 11920550
13. Plasma vitamin D metabolites and risk of colorectal cancer in women. D Feskanich J Ma CS Fuchs GJ Kirkner SE Hankinson BW Hollis EL Giovannucci, Cancer Epidemiol Biomarkers Prev 2004 13 1502 1508 15342452 (Pubitemid 39202318)
14. Dietary calcium, vitamin D, and the risk of colorectal cancer in Stockholm, Sweden. RS Pritchard JA Baron dV Gerhardsson, Cancer Epidemiol Biomarkers Prev 1996 5 897 900 8922297
15. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). E Giovannucci, Cancer Causes Control 2005 16 83 95 10.1007/s10552-004-1661-4 15868450
16. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. JF Aloia M Patel R Dimaano M Li-Ng SA Talwar M Mikhail S Pollack JK Yeh, Am J Clin Nutr 2008 87 1952 1958 18541590
17. Effect of vitamin D supplementation on vitamin D status and bone turnover markers in young adults. MS Barnes PJ Robson MP Bonham JJ Strain JM Wallace, Eur J Clin Nutr 2006 60 727 733 10.1038/sj.ejcn.1602374 16391584
18. Effect of vitamin D supplementation on bone health parameters of healthy young Indian women. N Malhotra A Mithal S Gupta M Shukla M Godbole, Arch Osteoporos 2009 4 47 53 10.1007/s11657-009-0026-8 20234858
19. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. DP Trivedi R Doll KT Khaw, BMJ 2003 326 469 10.1136/bmj.326.7387.469 12609940
20. [Effect of vitamin D supplementation on serum 25-hydroxyvitamin D and bone turnover markers concentrations in vegetarian children]. J Ambroszkiewicz W Klemarczyk J Gajewska M Chelchowska M Strucinska M Oltarzewski T Laskowska-Klita, Med Wieku Rozwoj 2009 13 34 39 19648657
21. Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. M Blum GE Dallal B Dawson-Hughes, J Am Coll Nutr 2008 27 274 279 18689559
22. The effect of intramuscular vitamin D (cholecalciferol) on serum 25OH vitamin D levels in older female acute hospital admissions. C Nugent K Roche S Wilson M Fitzgibbon D Griffin N Nichaidhin E Mulkerrin, Ir J Med Sci 2010 179 57 61 10.1007/s11845-009-0410-9 19714394
23. The effect of high-dose vitamin D supplementation on serum vitamin D levels and milk calcium concentration in lactating women and their infants. LA Basile SN Taylor CL Wagner RL Horst BW Hollis, Breastfeed Med 2006 1 27 35 10.1089/bfm.2006.1.27 17661558
24. High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. C von Restorff HA Bischoff-Ferrari R Theiler, Bone 2009 45 747 749 10.1016/j.bone.2009.06.012 19539796
25. Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney disease. D Rucker M Tonelli MG Coles S Yoo K Young AW McMahon, J Nephrol 2009 22 75 82 19229821
26. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. P Glendenning GT Chew HM Seymour MJ Gillett PR Goldswain CA Inderjeeth SD Vasikaran M Taranto AA Musk WD Fraser, Bone 2009 45 870 875 10.1016/j.bone.2009. 07.015 19631774
27. Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D. R Goswami N Gupta D Ray N Singh N Tomar, Br J Nutr 2008 100 526 529 10.1017/S0007114508921711 18252022
28. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. KD Crew E Shane S Cremers DJ McMahon D Irani DL Hershman, J Clin Oncol 2009 27 2151 2156 10.1200/JCO.2008.19.6162 19349547
29. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. QJ Khan PS Reddy BF Kimler P Sharma SE Baxa AP O'Dea JR Klemp CJ Fabian, Breast Cancer Res Treat 2010 119 111 118 10.1007/s10549-009-0495-x 19655244
30. Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer. X Nogues S Servitja MJ Pena D Prieto-Alhambra R Nadal L Mellibovsky J Albanell A Diez-Perez I Tusquets, Maturitas 2010 66 3 291 7 10.1016/j.maturitas.2010.03.012 20399042
31. Improving the measurement of 25-hydroxyvitamin D. AM Wootton, Clin Biochem Rev 2005 26 33 36 16278775
32. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. DL Ersfeld DS Rao JJ Body JL Sackrison AB Miller N Parikh TL Eskridge A Polinske GT Olson GD MacFarlane, Clin Biochem 2004 37 867 874 10.1016/j.clinbiochem.2004.06.006 15369717
33. Vitamin D deficiency. MF Holick, N Engl J Med 2007 357 266 281 10.1056/NEJMra070553 17634462
34. Vitamin D: what is an adequate vitamin D level and how much supplementation is necessary? H Bischoff-Ferrari, Best Pract Res Clin Rheumatol 2009 23 789 795 10.1016/j.berh.2009.09.005 19945690
35. The prevalence of vitamin D deficiency and insufficiency in a hematology-oncology clinic. PC Everett, Clin J Oncol Nurs 2008 12 33 35 10.1188/08.CJON.33-35 18258572
36. Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. MG Fakih DL Trump CS Johnson L Tian J Muindi AY Sunga, Int J Colorectal Dis 2009 24 219 224 10.1007/s00384-008-0593-y 18830610
37. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. ML Neuhouser B Sorensen BW Hollis A Ambs CM Ulrich A McTiernan L Bernstein S Wayne F Gilliland K Baumgartner R Baumgartner R Ballard-Barbash, Am J Clin Nutr 2008 88 133 139 18614733
38. Evaluation of vitamin D deficiency in breast cancer patients on bisphosphonates. A Wang-Gillam DA Miles LF Hutchins, Oncologist 2008 13 821 827 10.1634/theoncologist.2008-0013 18614589
39. Optimizing vitamin D status to reduce colorectal cancer risk: an evidentiary review. G Zhou J Stoitzfus BA Swan, Clin J Oncol Nurs 2009 13 3 E17 10.1188/09.CJON.E3-E17 19648087
40. Body fat and cholecalciferol supplementation in elderly homebound individuals. MH Canto-Costa I Kunii OM Hauache, Braz J Med Biol Res 2006 39 91 98 10.1590/S0100-879X2006000100011 16400469
41. Vitamin D insufficiency in older female community-dwelling acute hospital admissions and the response to supplementation. E DeLappe C McGreevy N ni Chadhain H Grimes T O'Brien E Mulkerrin, Eur J Clin Nutr 2006 60 1009 1015 10.1038/sj.ejcn.1602412 16538240
42. Plasma vitamin D and 25OHD responses of young and old men to supplementation with vitamin D3. SS Harris B Dawson-Hughes, J Am Coll Nutr 2002 21 357 362 12166534
43. Supplements of 20 microg/d cholecalciferol optimized serum 25-hydroxyvitamin D concentrations in 80% of premenopausal women in winter. ML Nelson JM Blum BW Hollis C Rosen SS Sullivan, J Nutr 2009 139 540 546 10.3945/jn.108.096180 19158226
44. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. HM Trang DE Cole LA Rubin A Pierratos S Siu R Vieth, Am J Clin Nutr 1998 68 854 858 9771862
45. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. MJ Barger-Lux RP Heaney S Dowell TC Chen MF Holick, Osteoporos Int 1998 8 222 230 10.1007/s001980050058 9797906
46. Dose response to vitamin D supplementation among postmenopausal African American women. SA Talwar JF Aloia S Pollack JK Yeh, Am J Clin Nutr 2007 86 1657 1662 18065583
47. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. RP Heaney KM Davies TC Chen MF Holick MJ Barger-Lux, Am J Clin Nutr 2003 77 204 210 12499343